Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial

Title
Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial
Authors
Keywords
Ustekinumab, Crohn’s Disease, Long-Term Extension
Journal
Publisher
Elsevier BV
Online
2021-02-21
DOI
10.1016/j.cgh.2021.02.025

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search